Position in CRDF
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$91,212
-$571,478 QoQ
Shares Held
56,306
-76.1% QoQ
Ownership
0.082%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 83%
Shared 0%
None 17%
Common Shares in CRDF Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $15,425,095,484 across 521 Biotechnology names. CRDF ranks #357 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
43,571,633 | $2,090,131,227 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
51,828,325 | $1,435,644,595 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,188,881 | $1,423,962,911 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,319,329 | $1,019,366,352 | |
| 5 | TECH |
BIO-TECHNE Corp
|
8,532,873 | $445,927,935 | |
| 6 | MRNA |
Moderna, Inc.
|
8,471,263 | $430,340,154 | |
| 7 | ARGX |
Argenx SE
|
560,711 | $409,459,203 | |
| 8 | APLS |
Apellis Pharmaceuticals, Inc.
|
10,042,399 | $404,005,708 |
All Filings in CRDF
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $91,212 | 56,306 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $662,690 | 235,834 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $639,954 | 310,659 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $2,506,597 | 795,746 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $2,193,376 | 698,528 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $2,353,965 | 542,389 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $1,330,036 | 498,142 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $1,139,356 | 513,224 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $424,128 | 79,425 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $22,555 | 15,240 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $26,408 | 19,000 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $23,096 | 15,713 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $336,348 | 203,848 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $393,072 | 280,766 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $580,171 | 376,736 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $800,180 | 363,719 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $524,405 | 211,454 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $3,311,352 | 550,974 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $719,944 | 108,100 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $3,108,614 | 467,461 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $235,101 | 25,389 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $312,503 | 17,371 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $164,886 | 11,620 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $121,938 | 24,339 | Shares | Defined | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||